Selected research
Market Structure
Global Pets External Dewormer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pets External Dewormer market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pets External Dewormer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pets External Dewormer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pets External Dewormer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pets External Dewormer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pets External Dewormer include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Chanelle, Elanco, Vetoquinol, Virbac, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pets External Dewormer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pets External Dewormer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pets External Dewormer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pets External Dewormer market size, projected growth trends, production technologies, key applications, and end-use industries.
Pets External Dewormer Segment by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Chanelle
Elanco
Vetoquinol
Virbac
Bayer
Merck
Zoetis
Pets External Dewormer Segment by Type
Injection
Unguent
Pets External Dewormer Segment by Application
Cats
Dogs
Other
Pets External Dewormer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets External Dewormer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pets External Dewormer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets External Dewormer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pets External Dewormer market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pets External Dewormer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pets External Dewormer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pets External Dewormer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Unguent
Applications
- Cats
- Dogs
- Other
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Chanelle
- Elanco
- Vetoquinol
- Virbac
- Bayer
- Merck
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pets External Dewormer Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pets External Dewormer Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pets External Dewormer Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pets External Dewormer Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pets External Dewormer Market Dynamics
- 2.1 Pets External Dewormer Industry Trends
- 2.2 Pets External Dewormer Industry Drivers
- 2.3 Pets External Dewormer Industry Opportunities and Challenges
- 2.4 Pets External Dewormer Industry Restraints
3 Pets External Dewormer Market by Manufacturers
- 3.1 Global Pets External Dewormer Revenue by Manufacturers (2021-2026)
- 3.2 Global Pets External Dewormer Sales by Manufacturers (2021-2026)
- 3.3 Global Pets External Dewormer Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pets External Dewormer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pets External Dewormer Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pets External Dewormer Manufacturers, Product Type & Application
- 3.7 Global Pets External Dewormer Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pets External Dewormer Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pets External Dewormer Players Market Share by Revenue in 2025
- 3.8.3 2025 Pets External Dewormer Tier 1, Tier 2, and Tier 3
4 Pets External Dewormer Market by Type
- 4.1 Pets External Dewormer Type Introduction
- 4.1.1 Injection
- 4.1.2 Unguent
- 4.2 Global Pets External Dewormer Sales by Type
- 4.2.1 Global Pets External Dewormer Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pets External Dewormer Sales by Type (2021-2032)
- 4.2.3 Global Pets External Dewormer Sales Market Share by Type (2021-2032)
- 4.3 Global Pets External Dewormer Revenue by Type
- 4.3.1 Global Pets External Dewormer Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pets External Dewormer Revenue by Type (2021-2032)
- 4.3.3 Global Pets External Dewormer Revenue Market Share by Type (2021-2032)
5 Pets External Dewormer Market by Application
- 5.1 Pets External Dewormer Application Introduction
- 5.1.1 Cats
- 5.1.2 Dogs
- 5.1.3 Other
- 5.2 Global Pets External Dewormer Sales by Application
- 5.2.1 Global Pets External Dewormer Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pets External Dewormer Sales by Application (2021-2032)
- 5.2.3 Global Pets External Dewormer Sales Market Share by Application (2021-2032)
- 5.3 Global Pets External Dewormer Revenue by Application
- 5.3.1 Global Pets External Dewormer Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pets External Dewormer Revenue by Application (2021-2032)
- 5.3.3 Global Pets External Dewormer Revenue Market Share by Application (2021-2032)
6 Global Pets External Dewormer Sales by Region
- 6.1 Global Pets External Dewormer Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pets External Dewormer Sales by Region (2021-2032)
- 6.2.1 Global Pets External Dewormer Sales by Region (2021-2026)
- 6.2.2 Global Pets External Dewormer Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pets External Dewormer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pets External Dewormer Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pets External Dewormer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pets External Dewormer Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pets External Dewormer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pets External Dewormer Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pets External Dewormer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pets External Dewormer Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pets External Dewormer Revenue by Region
- 7.1 Global Pets External Dewormer Revenue by Region
- 7.1.1 Global Pets External Dewormer Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pets External Dewormer Revenue by Region (2021-2026)
- 7.1.3 Global Pets External Dewormer Revenue by Region (2027-2032)
- 7.1.4 Global Pets External Dewormer Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pets External Dewormer Revenue (2021-2032)
- 7.2.2 North America Pets External Dewormer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pets External Dewormer Revenue (2021-2032)
- 7.3.2 Europe Pets External Dewormer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pets External Dewormer Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pets External Dewormer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pets External Dewormer Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pets External Dewormer Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bimeda Animal Health
- 8.1.1 Bimeda Animal Health Company Information
- 8.1.2 Bimeda Animal Health Business Overview
- 8.1.3 Bimeda Animal Health Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bimeda Animal Health Pets External Dewormer Product Portfolio
- 8.1.5 Bimeda Animal Health Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Pets External Dewormer Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Ceva Sante Animale
- 8.3.1 Ceva Sante Animale Company Information
- 8.3.2 Ceva Sante Animale Business Overview
- 8.3.3 Ceva Sante Animale Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ceva Sante Animale Pets External Dewormer Product Portfolio
- 8.3.5 Ceva Sante Animale Recent Developments
- 8.4 Chanelle
- 8.4.1 Chanelle Company Information
- 8.4.2 Chanelle Business Overview
- 8.4.3 Chanelle Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Chanelle Pets External Dewormer Product Portfolio
- 8.4.5 Chanelle Recent Developments
- 8.5 Elanco
- 8.5.1 Elanco Company Information
- 8.5.2 Elanco Business Overview
- 8.5.3 Elanco Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Elanco Pets External Dewormer Product Portfolio
- 8.5.5 Elanco Recent Developments
- 8.6 Vetoquinol
- 8.6.1 Vetoquinol Company Information
- 8.6.2 Vetoquinol Business Overview
- 8.6.3 Vetoquinol Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Vetoquinol Pets External Dewormer Product Portfolio
- 8.6.5 Vetoquinol Recent Developments
- 8.7 Virbac
- 8.7.1 Virbac Company Information
- 8.7.2 Virbac Business Overview
- 8.7.3 Virbac Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Virbac Pets External Dewormer Product Portfolio
- 8.7.5 Virbac Recent Developments
- 8.8 Bayer
- 8.8.1 Bayer Company Information
- 8.8.2 Bayer Business Overview
- 8.8.3 Bayer Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bayer Pets External Dewormer Product Portfolio
- 8.8.5 Bayer Recent Developments
- 8.9 Merck
- 8.9.1 Merck Company Information
- 8.9.2 Merck Business Overview
- 8.9.3 Merck Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Merck Pets External Dewormer Product Portfolio
- 8.9.5 Merck Recent Developments
- 8.10 Zoetis
- 8.10.1 Zoetis Company Information
- 8.10.2 Zoetis Business Overview
- 8.10.3 Zoetis Pets External Dewormer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zoetis Pets External Dewormer Product Portfolio
- 8.10.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pets External Dewormer Value Chain Analysis
- 9.1.1 Pets External Dewormer Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pets External Dewormer Production Mode & Process
- 9.2 Pets External Dewormer Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pets External Dewormer Distributors
- 9.2.3 Pets External Dewormer Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst